Basel Medical (BMGL) Debt to Equity (2024 - 2025)
Basel Medical recorded quarterly Debt to Equity of $0.93 in Q2 2025, up 143.91% quarter-over-quarter from $0.38 in Q2 2024, and up 143.91% year-over-year from $0.38 in Q2 2024.
Basel Medical's Debt to Equity history runs 2 years deep, the most recent figure standing at $0.93 for Q2 2025.
- In Q2 2025, Debt to Equity rose 143.91% year-over-year to $0.93; the TTM figure through Jun 2025 stood at $0.93 (up 143.91% YoY), while the FY2025 annual figure was $0.91, up 138.33% from the prior year.
- Debt to Equity came in at $0.93 for Q2 2025 at Basel Medical, up from $0.38 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.93 in Q2 2025 to a low of $0.38 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | -16.13 |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 2.74 |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | -22.31 |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 0.78 |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 0.06 |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 0.63 |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 0.55 |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 0.11 |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 0.05 |
| 10 | Basel Medical | 8.57 Mn | 6.23 Mn | - | 0.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.93 |
| Jun 30, 2024 | 0.38 |